NASDAQ: INSMInsmed Inc Stock Ownership - Who owns Insmed?
Insider buying vs selling
Have Insmed Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William Lewis | Chair and CEO | 2026-03-05 | 3,899 | $146.66 | $571.83kSell |
| William Lewis | Chair and CEO | 2026-03-05 | 6,259 | $30.46 | $190.65kBuy |
| William Lewis | Chair and CEO | 2026-03-05 | 4,440 | $17.16 | $76.19kBuy |
| William Lewis | Chair and CEO | 2026-03-05 | 2,083 | $144.23 | $300.43kSell |
| William Lewis | Chair and CEO | 2026-03-05 | 2,128 | $147.54 | $313.97kSell |
| William Lewis | Chair and CEO | 2026-03-05 | 2,589 | $145.27 | $376.10kSell |
| Michael Alexander Smith | Chief Legal Officer | 2026-02-24 | 4,151 | $155.06 | $643.65kSell |
| Michael Alexander Smith | Chief Legal Officer | 2026-02-24 | 15,771 | $156.53 | $2.47MSell |
| Michael Alexander Smith | Chief Legal Officer | 2026-02-24 | 20,248 | $17.07 | $345.63kBuy |
| Michael Alexander Smith | Chief Legal Officer | 2026-02-24 | 4,852 | $153.93 | $746.87kSell |
INSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INSM insiders and whales buy or sell their stock.
INSM Shareholders
What type of owners hold Insmed Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jpmorgan Chase Co | 10.76% | 23,199,512 | $3.25B | Institution |
| Richard S. Kollender | 10.17% | 21,924,540 | $3.07B | Insider |
| Vanguard Group Inc | 9.78% | 21,076,344 | $2.95B | Institution |
| Darwin Global Management Ltd | 9.71% | 20,933,277 | $2.93B | Institution |
| Blackrock Inc | 6.99% | 15,065,052 | $2.11B | Institution |
| Fmr LLC | 4.61% | 9,927,936 | $1.39B | Institution |
| Baker Bros Advisors LP | 3.06% | 6,592,746 | $923.84M | Institution |
| State Street Corp | 2.41% | 5,201,744 | $728.92M | Institution |
| Capital International Investors | 2.39% | 5,151,671 | $721.90M | Institution |
| Artisan Partners Limited Partnership | 2.25% | 4,843,749 | $678.75M | Institution |
INSM vs Biotech Stocks
Insmed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.